Navigation Links
EndyMed Medical's Novel Multi-Source Radiofrequency Device Enables Real Time Skin Impedance Measurements
Date:3/23/2011

CAESAREA, Israel, March 23, 2011 /PRNewswire/ -- EndyMed Medical, Ltd., www.endymed.com, a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today the publication of the latest peer reviewed paper on 3DEEP radiofrequency technology, "A novel method for real-time skin impedance measurement during radiofrequency skin tightening treatments". This article was published in the March 2011 issue of the Journal of Cosmetic Dermatology (Journal of Cosmetic Dermatology, Volume 10, Issue 1, pages 24-29, March 2011).

(Photo: http://photos.prnewswire.com/prnh/20110323/NE70202 )

EndyMed Medical has uniquely documented the advantages of skin impedance measurements as a necessary component in the delivery of predictable results when using radiofrequency energy in aesthetic medicine procedures.  The ability of EndyMed PRO, EndyMed's flagship product, to perform real time skin impedance measurements using proprietary 3DEEP RF technology, means that skin treatments performed with this device will typically have more predictable results.

"Our results confirm previous data which showed that skin impedance is highly variable between individual patients. We found that skin impedance varies in the same person on different days, and even during the same treatment procedure," said Yoram Harth, MD, a dermatologist, a founder of EndyMed Medical and one of the authors of the article.  "The real time impedance measurement implemented in the EndyMed PRO device allows optimal delivery of energy to the patient's skin independent of any changes in impedance, which increases the predictability of results."  

According to EndyMed CEO, Uzi Blumensohn, "Most RF treatment systems on the market cannot customize energy delivery to changes in skin impedance. We believe that our built-in impedance measurement mechanism is a major advantage for the patients and physicians, globally, using EndyMed PRO."

Among the key highlights of this paper are the following points:

  1. More than 6,000 unique skin impedance measurements on 22 patients were taken to substantiate the conclusions of this peer reviewed paper.
  2. Data showed an average session impedance range was 215-584 Ohms with an average of 369 Ohms.  Analysis of individual pulses (total of 6,000 readings) showed a significant decrease in impedance during the pulse. These findings validate the expected differences in skin impedance between individual patients and in the same patients during the treatment pulse.
  3. The clinical study was based on 30 patients whose results showed a high predictability of efficacy (86.7% of patients had good results or better at 3 months follow-up and a decrease of 2 or more grades in Fitzpatrick's wrinkle scale).

EndyMed Medical's proprietary 3DEEP RF technology is a multi-source, phase-controlled radiofrequency energy source that is state-of-the-art, safe and effective. 3DEEP represents the latest development in the evolution of RF-based professional skin treatment systems. 3DEEP uses multiple RF sources and sophisticated software to effectively control the phase of the energy flowing between the handpiece electrodes.  This method enables delivery of controlled heat deep into the skin, in a non-ablative or fractionally ablative way.  3DEEP technology is used in products which are FDA cleared and CE marked.

For more information, visit www.endymed.com or contact us at the contact details below.

About EndyMed Medical, Ltd.EndyMed Medical, Ltd. develops clinical solutions to rejuvenate aging and environmentally damaged skin. EndyMed is dedicated to providing the most effective products for the leading, global aesthetic treatments.  The company pioneered the development of multi-source radiofrequency technology, branded 3DEEP© RF, which is used in micro-ablative fractional and non-ablative aesthetic treatments. 3DEEP RF enables safe and effective results with minimal recovery time.  In August 2009, the EndyMed PRO multi-application platform was the world's first multi-source non-ablative radiofrequency device to be FDA cleared for the treatment of mild to moderate facial wrinkles.  In February 2011, the EndyMed PRO Fractional Skin Resurfacing Applicator, which enables simultaneous epidermal fractional ablation and deep dermal volumetric heating, became the world's first multi-source, fractionally ablative radiofrequency device to be FDA cleared for skin resurfacing.

EndyMed's management, clinical, marketing and R&D teams have extensive experience in the medical aesthetic market.  With proprietary 3DEEP radiofrequency technology and proprietary products like EndyMed PRO, the company is committed to changing the way aesthetic professionals perform fractional skin resurfacing, treat wrinkles, and provide skin tightening and body contouring solutions. EndyMed markets and supports its products in an ever increasing number of countries globally. Contact:  

Ann Berzak(m) +972 54 300 3269(e)  annb@endymed.comwww.endymed.comDistributor in USA:Eclipse Aesthetics, LLC.(t) 972 380 2911www.eclipseaesthetics.com©2011 EndyMed Medical, Ltd. All rights reserved. EndyMed Medical™, EndyMed PRO™ 3DEEP® and 3DEEP Fractional Skin Resurfacing™ are trademarks or registered trademarks of EndyMed Medical, Ltd.


'/>"/>
SOURCE EndyMed
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alzheimers Drug Discovery Foundation Supports ADispell Technology with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
2. Novel Gene Therapy Agent NLX-P101 Effective in Treating Parkinsons Disease in Phase 2 Trial
3. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
4. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
5. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
6. Reportlinker Adds Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
7. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
10. Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
11. Novel Night Time Healing is Key to Shoulder Pain Relief From ROTATORELIEVER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):